Annual FCF
-$23.97 M
+$3.32 M+12.18%
December 31, 2023
Summary
- As of March 7, 2025, CRVS annual free cash flow is -$23.97 million, with the most recent change of +$3.32 million (+12.18%) on December 31, 2023.
- During the last 3 years, CRVS annual FCF has risen by +$10.88 million (+31.23%).
- CRVS annual FCF is now -83.32% below its all-time high of -$13.07 million, reached on December 31, 2015.
Performance
CRVS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.32 M
-$840.00 K-15.33%
September 30, 2024
Summary
- As of March 7, 2025, CRVS quarterly free cash flow is -$6.32 million, with the most recent change of -$840.00 thousand (-15.33%) on September 30, 2024.
- Over the past year, CRVS quarterly FCF has dropped by -$887.00 thousand (-16.32%).
- CRVS quarterly FCF is now -178.83% below its all-time high of -$2.27 million, reached on June 30, 2015.
Performance
CRVS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$22.13 M
-$887.00 K-4.18%
September 30, 2024
Summary
- As of March 7, 2025, CRVS TTM free cash flow is -$22.13 million, with the most recent change of -$887.00 thousand (-4.18%) on September 30, 2024.
- Over the past year, CRVS TTM FCF has increased by +$4.22 million (+16.03%).
- CRVS TTM FCF is now -735.57% below its all-time high of -$2.65 million, reached on March 31, 2015.
Performance
CRVS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CRVS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.2% | -16.3% | +16.0% |
| 3 y3 years | +31.2% | +16.2% | +18.9% |
| 5 y5 years | +42.0% | +16.2% | +18.9% |
CRVS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.7% | -22.6% | +22.4% | -5.5% | +39.7% |
| 5 y | 5-year | at high | +35.8% | -22.6% | +50.0% | -5.5% | +41.9% |
| alltime | all time | -83.3% | +48.4% | -178.8% | +50.8% | -735.6% | +52.4% |
Corvus Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.32 M(+15.3%) | -$22.13 M(+4.2%) |
| Jun 2024 | - | -$5.48 M(+6.3%) | -$21.24 M(+1.2%) |
| Mar 2024 | - | -$5.16 M(-0.2%) | -$20.98 M(-12.5%) |
| Dec 2023 | -$23.97 M(-12.2%) | -$5.17 M(-4.9%) | -$23.97 M(-9.0%) |
| Sep 2023 | - | -$5.43 M(+4.0%) | -$26.35 M(-6.3%) |
| Jun 2023 | - | -$5.22 M(-35.9%) | -$28.11 M(-3.1%) |
| Mar 2023 | - | -$8.14 M(+7.9%) | -$29.01 M(+6.3%) |
| Dec 2022 | -$27.29 M(-25.7%) | -$7.55 M(+4.9%) | -$27.29 M(+2.6%) |
| Sep 2022 | - | -$7.19 M(+17.4%) | -$26.60 M(-4.4%) |
| Jun 2022 | - | -$6.13 M(-4.6%) | -$27.83 M(-19.0%) |
| Mar 2022 | - | -$6.42 M(-6.3%) | -$34.35 M(-6.4%) |
| Dec 2021 | -$36.72 M(+5.4%) | -$6.86 M(-18.6%) | -$36.72 M(-3.5%) |
| Sep 2021 | - | -$8.43 M(-33.4%) | -$38.07 M(+1.6%) |
| Jun 2021 | - | -$12.65 M(+43.9%) | -$37.45 M(+9.2%) |
| Mar 2021 | - | -$8.79 M(+7.1%) | -$34.29 M(-1.6%) |
| Dec 2020 | -$34.85 M(-6.7%) | -$8.21 M(+5.1%) | -$34.85 M(-0.9%) |
| Sep 2020 | - | -$7.81 M(-17.7%) | -$35.16 M(-7.4%) |
| Jun 2020 | - | -$9.49 M(+1.4%) | -$37.97 M(+0.7%) |
| Mar 2020 | - | -$9.35 M(+9.8%) | -$37.69 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$37.35 M(-9.7%) | -$8.52 M(-19.8%) | -$37.35 M(+0.3%) |
| Sep 2019 | - | -$10.61 M(+15.2%) | -$37.22 M(-0.9%) |
| Jun 2019 | - | -$9.21 M(+2.3%) | -$37.57 M(-4.4%) |
| Mar 2019 | - | -$9.01 M(+7.3%) | -$39.30 M(-4.9%) |
| Dec 2018 | -$41.34 M(-11.0%) | -$8.39 M(-23.4%) | -$41.34 M(-5.9%) |
| Sep 2018 | - | -$10.96 M(+0.1%) | -$43.92 M(+0.3%) |
| Jun 2018 | - | -$10.94 M(-1.0%) | -$43.78 M(-2.0%) |
| Mar 2018 | - | -$11.05 M(+0.7%) | -$44.67 M(-3.9%) |
| Dec 2017 | -$46.48 M(+54.6%) | -$10.97 M(+1.4%) | -$46.48 M(+2.1%) |
| Sep 2017 | - | -$10.82 M(-8.6%) | -$45.53 M(+9.7%) |
| Jun 2017 | - | -$11.83 M(-8.0%) | -$41.49 M(+13.2%) |
| Mar 2017 | - | -$12.86 M(+28.3%) | -$36.66 M(+22.0%) |
| Dec 2016 | -$30.06 M(+129.9%) | -$10.02 M(+47.7%) | -$30.06 M(+21.0%) |
| Sep 2016 | - | -$6.78 M(-3.1%) | -$24.84 M(+16.0%) |
| Jun 2016 | - | -$7.00 M(+12.0%) | -$21.41 M(+28.4%) |
| Mar 2016 | - | -$6.25 M(+30.2%) | -$16.68 M(+27.5%) |
| Dec 2015 | -$13.07 M | -$4.80 M(+43.0%) | -$13.07 M(+58.0%) |
| Sep 2015 | - | -$3.36 M(+48.1%) | -$8.27 M(+68.3%) |
| Jun 2015 | - | -$2.27 M(-14.4%) | -$4.92 M(+85.6%) |
| Mar 2015 | - | -$2.65 M | -$2.65 M |
FAQ
- What is Corvus Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual FCF year-on-year change?
- What is Corvus Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly FCF year-on-year change?
- What is Corvus Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM FCF year-on-year change?
What is Corvus Pharmaceuticals annual free cash flow?
The current annual FCF of CRVS is -$23.97 M
What is the all time high annual FCF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual free cash flow is -$13.07 M
What is Corvus Pharmaceuticals annual FCF year-on-year change?
Over the past year, CRVS annual free cash flow has changed by +$3.32 M (+12.18%)
What is Corvus Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of CRVS is -$6.32 M
What is the all time high quarterly FCF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly free cash flow is -$2.27 M
What is Corvus Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, CRVS quarterly free cash flow has changed by -$887.00 K (-16.32%)
What is Corvus Pharmaceuticals TTM free cash flow?
The current TTM FCF of CRVS is -$22.13 M
What is the all time high TTM FCF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM free cash flow is -$2.65 M
What is Corvus Pharmaceuticals TTM FCF year-on-year change?
Over the past year, CRVS TTM free cash flow has changed by +$4.22 M (+16.03%)